Agoracom Blog Home

Archive for the ‘Namaste Technologies Inc.’ Category

Namaste $N.ca Announces 2017 Audited Financials With Corporate Update $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 4:59 PM on Monday, January 8th, 2018

Nlogo

2017 Financials – Highlights

  • Net revenue of $11.0 million (2016 – $3.5 million),
  • An increase of $7.5 million or 215% year-over-year

VANCOUVER, British Columbia, Jan. 08, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce the filling of its audited financial statements, management discussion and analysis, and certification of annual filings for the year ended August 31st, 2017 (collectively, the “2017 Financials”).  The company’s 2017 gross revenue of C $10,981,414 which represents a 211% year-on-year growth increase was achieved through strategic acquisitions and consolidation of industry competitors, as well as through the implementation of advanced e-commerce technologies targeted to grow organic traffic and increase on-site conversion rates. Namaste expects to see strong revenue growth in its cannabis hardware business entering into 2018 through further optimization and expansion of operations in emerging markets. Namaste looks forward to soon receiving its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) medical cannabis “sales-only” license whereby the company will enter a new revenue vertical by selling medical cannabis through its online platform. Namaste believes its expertise in e-commerce and website optimization, along with its existing database of Canadian consumers, will propel the Company to becoming the largest distribution channel for the sale of medical cannabis online. During the 2017 financial period, all of Namaste’s revenue was driven through hardware sales and does not include any medical cannabis sales.

2017 Financials – Highlights

  • Net revenue of $11.0 million (2016 – $3.5 million), an increase of $7.5 million or 215% year-over-year. The increase in net revenue is primarily due to organic growth, and the acquisitions of Australian Vaporizers PTY Ltd., URT1 Limited and Haze Industries, Inc., which provided revenues of $2.1 million, $1.7 million and $1.3 million, respectively.
  • Gross profit of $1.4 million (2016 – $1.1 million), an increase of $0.3 million or 27% year-over-year. As a percentage of sales, the gross margin declined to 13% during the period, as compared to 32% in the prior year. The gross profit decline was primarily due to a non-cash inventory write-down of $0.6 million. Gross margin further declined due to a decrease in the price mark-up of products sold to retail customers, an increase in discounts issued to customers, an increase in shipping cost related to product sales, and a foreign currency depreciation in sales generated in British Sterling relative to the Canadian Dollar.
  • Operating costs were $19.5 million (2016 – $3.3 million), an increase of $16.2 million year-over-year. The increase in operating costs is primarily due to non-cash items such as stock-based compensation inventory write-downs, amortization of intangibles and an impairment of goodwill and intangible assets, which totaled $13.5 million. Excluding non-cash expenses, the increase in operating costs was comparable to the growth in revenue.  In addition to this, there were increases in administrative, consulting, advertising, and salary costs, which are in line with revenue growth. Lastly, there were non-recurring legal and consulting expenses of $0.4 million in relation to the acquisitions of URT1 Limited, Australian Vaporizers PTY Ltd. and CannMart Inc. during the period under review.
  • Net losses were $17.4 million (2016 – $1.9 million), an increase of $152 million year-over-year. The increase in net losses is primarily due to $13.5 million in non-cash charges.

2018 Strategic Initiatives

  • Official Launch of Namaste MD:

In November of 2017, Namaste soft-launched a beta version of its revolutionary telemedicine mobile application, NamasteMD.com, which is a virtual consultation portal that connects patients with nurse practitioners to facilitate issuance of medical documents. NamasteMD is presently available on desktop and Google Android platforms, while the Company is updating the iOS version and is awaiting approval in the Apple store. NamasteMD is the only virtual application for the Canadian medical cannabis industry that incorporates exclusive age and identity verification technology, utilizing facial recognition and direct connection to federal databases. NamasteMD.com is being implemented as a patient acquisitions tool for Namaste to leverage its existing database of Canadian consumers and daily site traffic. Initial testing user feedback has been taken into consideration, and the Company plans an official launch of the platform very soon.

  • Cannmart Medical Cannabis Marketplace:

In May of 2017, Namaste acquired Cannmart Inc. (“Cannmart”), a late stage applicant under Canada’s ACMPR program for a medical cannabis “sales-only” license. Namaste is presently under construction for a state-of-the-art processing facility with the intention of launching an online marketplace for medical cannabis that will include products from multiple domestic and international licensed producers. The Company is specifically focused on the international importation niche as it sees value in importing high quality medical cannabis from international markets like Israel, which leads the industry in cannabis research and development. NamasteMD patients will have immediate access to Cannmart’s online platform which will focus on carrying the largest variety of medical cannabis including oils, extracts, and edibles, when they become available in the Canadian market.  Cannmart will offer same-day delivery for medical cannabis products in the Greater Toronto Area (“GTA”) and will offer additional services including order fulfilment for out-of-province licensed producers as cannabis packaging and pre-filled strain cartridges. The Company will utilize its expertise in optimizing the consumer experience in an online platform and believes that Cannmart has the potential to become Canada’s leading retailer for medical cannabis.

  • Technology Implementations

Throughout 2017, Namaste developed several enterprise level software platforms out of necessity for its operations, including a fully integrated middleware solution. The Company also developed NamasteMD as described above which will affect the way patients connect with doctors or medical practitioners to issue medical documentation. Namaste believes that there is significant value in its software platforms and their potential use in partnerships with other industry leaders. Namaste, through its research of existing seed-to-sale software platforms, believes that there is a large gap in the industry for a software platform to provide a vertically integrated solution for medical cannabis retail sales and that the software could be made available and utilized across the industry. Namaste plans to explore software licensing opportunities as it sees demand for its technology across the industry.

  • Emerging Markets

Further to the Company’s 215% year-on-year increase in revenue, Namaste’s core business of hardware sales continues to grow rapidly through expansion into emerging markets like Mexico and Brazil, as well as in markets like Australia where the Company maintains a large market share. The Company’s marketing and SEO team are highly focused on increasing site traffic through strategic partnerships and improving on-site conversion rates by implementing new technology across its e-commerce platform. The Company expects to see continued growth through its hardware business both domestically and abroad.

  • Profitability:

Further to the Company’s news release dated December 22, 2018, Namaste signed a Fulfillment Agreement with Greenlane Canada, which represents a key component of Namaste’s strategy moving forward, and is expected to have an immediate impact on cash-flow. The partnership further demonstrates Namaste’s commitment to focusing its resources towards the expansion of its global network, in an attempt to solidify its place in the Canadian market as a dominant player. Namaste’s management remains focused on streamlining its current operations by taking cost cutting measures, such as the Greenlane partnership, to help fuel future growth and ultimately achieve profitability in early to mid 2018.

  • Market Penetration:

Namaste continues to establish itself as the leader in the development and deployment of cutting edge technology solutions specifically designed for the medical cannabis industry. Namaste believes these technological advances will play a vital role moving forward, in an attempt to provide Canadian users with a safe and reliable platform to help meet the growing demand for medical cannabis. As demonstrated in 2017, it remains highly evident that there is a significant demand for many of the products and services Namaste is able to provide and Namaste fully intend on continuing to pursue new opportunities in the Canadian market. In only a short time, Namaste has been able to take significant strides in penetrating the medical cannabis market by focusing its efforts on developing more efficient medical cannabis delivery systems that it believes will become industry standard. By working with many of Canada’s leading ACMPR licensed producers, Namaste believes it is well-positioned to exploit additional opportunities it has identified within the medical cannabis market, and fully anticipates seeing the further adoption of many of its existing technological initiatives moving forward. These agreements solidify our desire to work with top Canadian LP’s in an attempt to pursue growth in the medical cannabis online retail marketplace.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “2017 has been truly transformational for Namaste and its shareholders.  As a result of many new and exciting initiatives, Namaste was able to form many strategic partnerships over a relatively short period of time, and sees no sign of that trend slowing down moving into 2018. To have many of the largest Canadian LP’s see value in the products and services we provide is a true testament to both the need and desire for technological solutions within the medical cannabis industry. The industries keen interest in the adoption of our platform, further validates the inherent value our systems are able to bring, and it is extremely exciting to see our efforts being rewarded. Namaste sees major opportunities in expanding the software platform and in developing a more robust and advanced seed-to-sale platform, as it believes the industry is still lacking an appropriate vertically integrated solution that will allow for further growth of the Canadian medical cannabis online retail industry.

We will continue to innovate in the Canadian medical cannabis market, as we believe many of our initiatives will have first to market advantage as consumers look for more efficient and reliable sources of medical cannabis. With this in mind, we believe we have positioned ourselves extremely well to achieve profitability, as we remain focused on completing construction at the Cannmart facility in anticipation of receiving our ACMPR “sales-only” license. Once obtained, Namaste believes it will be one of the most well-positioned companies in the Canadian cannabis market, and will be able to offer a diverse range of products and services globally. We’re very excited going forward as the impressive revenue growth to-date having been derived from hardware sales only, presents Namaste with vast opportunity moving forward in the medical cannabis online retail industry.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk

Canadian #cannabis producers set their sights on global domination $N.ca $TBP.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 11:10 AM on Friday, January 5th, 2018

  • Medical research forcing an end to prohibition
  • “I’ve never experienced anything like this,” says Ranjeev Dhillon, a corporate lawyer and partner at the law firm Bennett Jones. Most of his practice now centres on the cannabis export business.
  • In recent months, more than a dozen countries have legalized medical marijuana

Medical marijuana consumers in Prague rang in 2018 with a new Canadian import, Tilray Milled Cannabis, a high THC marijuana product grown on Vancouver Island.

The Czech Republic is just the latest nation to sell Canadian weed, joining Germany, Australia, New Zealand and a growing list of other nations which are turning to Canada as a safe and legal source for medical grade cannabis.

In recent months, more than a dozen countries have legalized medical marijuana. New laws are pending in at least a dozen more as national regulators and even the World Health Organization recognize legitimate medical uses for a drug which had long been banned under international treaties.

The moves have sparked an unprecedented demand for legally grown, high quality marijuana, as well as the oil which is extracted from it. Seven Canadian producers have been granted licences to export the crop. By the end of March they will have sent 528 kilograms of dried cannabis flower and 911 litres of oil overseas. That may well be just an initial trickle, as the floodgates open on an international medical cannabis market.

“I’ve never experienced anything like this,” says Ranjeev Dhillon, a corporate lawyer and partner at the law firm Bennett Jones. Most of his practice now centres on the cannabis export business.

Brendan Kennedy of Tilray says Canada is the source of the safest product when regulators in other countries go looking for medical marijuana. (Evan Mitsui/CBC)

“I think it means that we’ll be a global player,” he says, stressing this is a positive development for the Canadian economy. “This could be our opportunity to be viewed the same as we are in mining or hockey. We’ll be world class and be world leaders and I think that will stay to be the case for a very, very long time.”

Medical research forcing an end to prohibition

For decades an international ban on the production and use of cannabis kept to a minimum any legitimate research into potential medical uses. Prohibition ensured that marijuana cultivation stayed in the hands of illegal growers, and distribution was limited to the criminal underground.

But many users saw value in cannabis as treatment for a variety of conditions, ranging from controlling epileptic seizures to pain relief to stress control.

Israeli scientist Raphael Mechoulam began limited research on the drug in the early 1960s, which led to the discovery of the human endocannabinoid system. By the mid-1990s, scientists determined that cannabinoid receptors play a vital role in the function of the human body. For the first time synthetic cannabinoid derivatives were approved for medical use, primarily for the treatment of nausea and wasting syndrome.

At the same time anecdotal evidence was building to suggest cannabis could have other, more widespread medical uses. Patients who claimed benefits from cannabis went to court seeking the right to use marijuana as medicine without facing the risk of criminal prosecution.

In 2000 the Ontario Court of Appeal ruled that Terry Parker, a man with severe epilepsy, should have the right to use marijuana to moderate his severe seizures.

One year later, Canada’s Medical Marijuana Access Program was introduced, allowing patients who had obtained a doctor’s consent to grow their own marijuana under a special permit. By 2013 more than 28,000 Canadians had been granted personal use production licences, leading to a flood of unregulated home-grow operations, and along with it a risk of fires, mould contamination in homes, and legally grown weed being diverted to the black market.

In an effort to crack down on the home grow-ops, the Harper Conservative government introduced new legislation that established legal grow operations which could provide medical marijuana through a mail order service. The Marijuana for Medical Purposes regulations, enacted in 2014, set Canada apart as the first nation to establish a regulated commercial cannabis cultivation industry.

Canadian pot finds a role in the world market

As Canada moves towards legal recreational weed in July, the number of licensed growers has swelled to 84, production is skyrocketing, and research into new growing techniques and improved strains is increasing exponentially. This has placed Canada in a unique role as other nations scramble to find safe and legal supplies of medical cannabis.

Cam Battley, executive vice president of Aurora, shows off Aurora Vie’s Pointe-Claire, Que., facility. Canadian producers have expertise in greenhouse technology, extraction methods, strains and genetics. (CBC)

“When regulators in other countries are looking for a product, Canada is really the source of the safest product. It’s the safest bet,” explains Brendan Kennedy, the CEO of Nanaimo-based Tilray, a pioneer in cannabis exports.

Tilray is among several Canadian producers already exporting to Germany, which established a widespread marijuana access program last spring. Not only is cannabis stocked in German pharmacies, the government pays for the drug under its government health insurance program.

Until it can establish a domestic industry, Germany is importing from Canada. Along with Tilray, Canadian producers Aurora, Cronos and Canopy Growth are tapping the German market. Aurora has even gone a step further, purchasing pharmaceutical supplier Pedanios, with an eye to expanding its distribution in the European market.

Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. Several others are following. A report published in November places the value of the European cannabis market at $84 billion Cdn a year.

That’s led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.

Beyond exports, Canada has expertise

“Part of the reason we decided to invest in a cultivation facility in Portugal was that we also saw a massive increase in demand for medical cannabis product in the EU,” explains Kennedy, who sees a bright future well beyond Canadian exports.

Canadian expertise in growing and greenhouse technology, extraction methods, strains and genetics, along with plain old business know-how, are also in demand. In addition to exports, Canada’s cannabis companies are also teaming up with local partners to build facilities in Germany, Denmark and Israel.

Australia is seen as another prize for Canadian producers. When it announced last February that it would allow importation, Canadian producers Aurora, CannTrust, Canopy, MedReleaf and Tilray swooped in, not only with bags of weed and vials of oil, but with partnerships to build facilities there.

Peru and Mexico have also passed legislation to legalize medical cannabis, and Canadian companies are promising further announcements soon. Overall, they say, the world market could be worth around $200 billion.

What it all means

The rapid legalization of medical cannabis has spurred new research into potential treatments using the drug. In Israel, where the medical research began, there are about 120 trials underway using components of the marijuana plant.

Neil Closner, CEO of Ontario-based MedReleaf, believes Canadian medical marijuana producers have the potential to become global giants. (Canadian Press)

As cures and treatments are discovered and proven, the role of cannabis is sure to expand, creating even greater potential beyond flowers and oil. CEO of Markham-based MedReleaf Neil Closner believes at least two or three of Canada’s producers will become global giants.

“I think overall who wins is Canada. I think we’ve got a leg up on the rest of the world, which is very exciting at a national level for us. I’d like to think that MedReleaf is strongly positioned to be one of the few handfuls of global winners.”

And while California is the latest U.S. state to legalize marijuana, American producers are shut out of the global market because of the federal prohibition on the drug.

That leaves Canada room to pursue the international market and all the potential riches that go with it.

Source: http://www.cbc.ca/news/business/medical-marijuana-canadian-export-1.4470407

Namaste $N.ca $NXTTF Live 420 Stream: Latest Press Releases | Aurora Cannabis $ACB.ca – Live Today At 4.20pm EST

Posted by AGORACOM-JC at 4:05 PM on Wednesday, January 3rd, 2018

INTERVIEW: Namaste $N.ca $NXTTF Discusses Strategic Private-Label Software and Patient Referral Agreements with Aurora Cannabis $ACB.ca $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 4:33 PM on Tuesday, January 2nd, 2018

Aurora $ACB.ca and Namaste $N.ca $NXTTF to Complete Strategic Private-Label Software and Patient Referral Agreements $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 7:19 AM on Tuesday, January 2nd, 2018

Nlogo

  • Namaste will provide CanvasRx with a customized, CanvasRx-branded version of NamasteMD
  • Namaste will provide CanvasRx with a two-year exclusivity period for the private label version of NamsteMD.com in Canada

EDMONTON and VANCOUVER, Jan. 2, 2018 – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. (“Namaste”) (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced the signing of a binding term sheet towards a final Private-Label Software Agreement (“Private Label Agreement”), whereby Namaste will provide Aurora’s wholly-owned subsidiary, CanvasRx Inc. (“CanvasRx”) with a customized version of Namaste’s patient acquisition tool, NamasteMD.com (“NamasteMD”),  as well as desktop and mobile applications for Google Android and Apple iOS platforms. The companies have 30 days to complete a final agreement.

Private Label Agreement

NamasteMD is an online telemedicine platform for patient consultation and registration, bringing together Namaste`s tested technology platform, including certain proprietary authentication technologies, as well as consultation, education and medical document issuance processes. Under the terms of the Private Label Agreement:

  • Namaste will provide CanvasRx with a customized, CanvasRx-branded version of NamasteMD
  • Namaste will provide CanvasRx with a two-year exclusivity period for the private label version of NamsteMD.com in Canada
  • Namaste will initially provide the application for both the Google Android and Apple iOS platforms
  • CanvasRx will require their own doctors and/or nurse practitioners to operate the platform
  • Commercial terms of the agreement are not disclosed
  • In consideration of Aurora’s assistance for the future optimization of NamasteMD, Namaste has issued Aurora 500,000 stock options, exercisable at $3.35 per common share for 48 months, vesting quarterly over 12 months.

Support Services Agreement

In addition, the companies have also signed a non-binding, non-exclusive Letter of Intent to complete a final Consultation & Support Services Agreement (“Consultation Agreement”), whereby Namaste will provide patient referral services to Aurora, where applicable under Canada’s Access to Cannabis for Medical Purposes (“ACMPR”) regulations. Under the terms of the Consultation Agreement:

  • Namaste shall provide certain patient-focused education and strain selection services, as well as assistance in preparing the requisite paperwork (Medical Documentation) for registering patients with Aurora
  • The Agreement is non-exclusive for a one-year term
  • Namaste shall provide the services under the agreement on preferential terms to Aurora
  • Commercial terms of the Consultation Agreement are not disclosed

The agreements further strengthen the strategic ties between the two companies, who already collaborate on eCommerce (sale of Namaste-sourced, curated selection of vaporizers through Aurora website, utilizing Namaste’s technology platform), and the distribution of BC Northern Lights products. Once completed, the new agreements will provide Namaste with recurring revenues through the private label platform, while Aurora will be the only licensed producer able to offer Namaste`s streamlined online patient acquisition platform under its own (CanvasRx) brand.

Management Commentary

“NamasteMD provides an innovative and efficient extension to our industry-leading in-person cannabis counseling and education services provided through CanvasRx,” said Terry Booth, CEO. “The new platform will enable us to extend our industry leading patient care to areas where we currently have no physical presence. This will allow us to leverage the strength of both the CanvasRx and Aurora brands, without having to commit to substantial investments in brick and mortar facilities. Namaste is a trusted partner with whom we already successfully collaborate on two promising initiatives, and we look forward to extending our partnership based on innovation and customer care excellence.”

Sean Dollinger, President and CEO of Namaste added, “We are thrilled to have Aurora, the industry’s most innovative and dynamic Licensed Producer, as our preferred strategic partner. Our drive to innovate meets the cannabis industry`s need for reliable technological solutions to improve operational efficiencies and expand the customer experience. We are very proud to be aligned with Aurora’s team, and look forward to executing on our ongoing collaboration.”

About Aurora

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as “Aurora Mountain”, a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal’s West Island, and is currently constructing an 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, as well as is completing a fourth facility in Lachute, Quebec through its wholly owned subsidiary Aurora Larssen Projects Ltd.

In addition, the Company holds approximately 17.23% of the issued shares in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 22.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens. Aurora’s common shares trade on the TSX under the symbol “ACB”.

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany, and has opened new supply channels into emerging markets, including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Boards of Directors

Terry Booth

Sean Dollinger

Chief Executive Officer

Chief Executive Officer

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Aurora and Namaste are under no obligation, and expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX or CSE, nor their Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange and CSE) accept responsibility for the adequacy or accuracy of this release.

Namaste $N.ca Announces Wholesale Supply LOI With Israel-Based BRLEV $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:42 AM on Wednesday, December 27th, 2017

Nlogo

  • Signed a Letter of Intent (“LOI”) with BRLEV AGRICULTURAL CROPS LTD
  • BRLEV will supply CannMart with high quality medical cannabis, to be imported by CannMart from Israel and offered in the Company’s online marketplace

VANCOUVER, British Columbia, Dec. 27, 2017 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRANKFURT:M5BQ)(OTCMKTS:NXTTF) is pleased to announce that it has signed a Letter of Intent (“LOI”) with BRLEV AGRICULTURAL CROPS LTD. (“BRLEV”), through its wholly owned subsidiary, Cannmart Inc. (“CannMart”), whereby BRLEV will supply CannMart with high quality medical cannabis, to be imported by CannMart from Israel and offered in the Company’s online marketplace. BRLEV is Israel’s largest licensed producer of medical cannabis, with over 40 years of experience in commercial agricultural production and export. BRLEV will work with Namaste to export medical cannabis to the Canadian market, which will fall under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) guidelines. The LOI and the proposed medical cannabis supply agreement (“Supply Agreement”) highlight Namaste’s intentions of becoming Canada’s leading online retailer for medical cannabis products, by focusing on importation of high quality medical cannabis from industry-leading countries like Israel. Namaste believes that the demand for imported cannabis and the opportunity it presents has been largely overlooked. This deal solidifies Namaste’s commitment in seeking the best cannabis products in global markets and offering them to Canadian cannabis users.

Terms of the LOI:

  • Namaste will submit purchase orders to BRLEV for medical cannabis.
  • Namaste will provide 50% payment against each purchase order once the goods arrive at the airport and have been tested by a third-party laboratory facility. The balance of payment will be due within 30 days from the shipment date.
  • Product cost to Namaste will be determined as 30% of Namaste’s retail price.
  • Namaste will be responsible for shipping and import costs.
  • Namaste’s product branding and naming conventions for each strain will adhere to Israeli government requirements where applicable.
  • Namaste will mark each customer package with BRLEV’s name and logo.

The LOI and proposed Supply Agreement reinforce Namaste’s effort to provide imported medical cannabis products to its patients by offering the largest variety of products from domestic and international producers. BRLEV boasts one of the largest production facilities in Israel and is a strong partner for Namaste. Namaste believes that BRLEV’s existing license and infrastructure will be suited to accommodate the Company’s expected demand for high quality Israeli grown medical cannabis. Namaste is highly focused on cannabis importation for its CannMart facility and specifically on sourcing from the Israeli market. This partnership will allow Namaste to offer greater value for its patients by allowing CannMart to provide a larger offering in comparison with domestic ACMPR licensed producers.  The Company expects to see strong demand for imported cannabis products and looks forward to a growing relationship with BRLEV and its management team.

Management Commentary
Asaf Bardichev, President and CEO of BRLEV comments: “BRLEV is very excited to announce the signing of this LOI. We see Namaste as a central and leading figure in the growing Canadian retail market and see this as a great opportunity for collaboration. We believe that the partnership with Namaste that we are beginning now can be a long and lasting one. It will be one that strengthens Namaste, BRLEV, and the Canadian medical cannabis market.”

Sean Dollinger, President and CEO of Namaste comments: “While the Canadian market continues to be a leader with regards to the production of high quality cannabis, Namaste remains of the opinion that Canadian consumers will demand other high-quality products from markets abroad. Through our partnership with BRLEV, Namaste fully intends to meet that demand. This transaction represents the first of many partnerships by which Namaste intends to create the largest and most diverse marketplace for Canadian cannabis consumers. We are very pleased to have signed this LOI and are looking forward to working with the BRLEV Group. Namaste believes this represents a strong partnership based on BRLEV’s credentials and experience in cultivation and agricultural export. The BRLEV management team has exceptional talents for cultivation and production of the highest quality medical cannabis in the Israeli market. We look forward to working with BRLEV and their team in creating the most diverse offering of medical cannabis in the Canadian online retail marketplace.”

About BRLEV
The BRLEV Group manages cannabis based medicine production from mother plants to final product. The group is fully licensed in all aspects of cannabis cultivation and processing as well as in the manufacturing of cannabis based medication in Israel. With an impressive lineup of high-end facilities and over 40 years of experience in agriculture the BRLEV group meets the highest industry standards including GMP, Global Gap and Tesco. Working closely with the leading Israeli research bodies in plant genetics, virus and pest control, cannabis processing and active substance extraction, BRLEV uses state of the art methods and knowledge in cannabis cultivation and processing. The BRLEV group has also secured a cannabis trading license which enables the group to start exporting its products overseas as soon as export regulations are in place.

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

INTERVIEW: Namaste $N.ca Discusses Fulfillment Agreement With Greenlane $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 2:09 PM on Friday, December 22nd, 2017

Nlogo

  • Greenlane will provide order fulfillment for direct website and wholesale sales
  • Greenlane will provide all services related to inventory owned and maintained by Greenlane, including pulling, packing and shipping orders.
  • Greenlane will make a one-time purchase of inventory specified by Namaste based on 360-day payment terms, to ensure adequate inventory levels

Sean Dollinger, President and CEO of Namaste comments: “The signing of this agreement may very well be one of the most important initiatives Namaste has implemented to date, and may be the final piece of the puzzle in helping Namaste achieve profitability. The agreement itself represent months of negotiations which has culminated with an amazing partnership with easily the most influential business-to-business distributor in the space…”

Namaste $N.ca Signs Fulfillment Agreement With Greenlane $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:20 AM on Friday, December 22nd, 2017

Nlogo

  • Announced that its wholly owned subsidiary Cannmart Inc. has signed a Fulfilment Services Agreement with Greenlane Canada
  • Greenlane will fulfill orders for all products set forth in Greenlane’s product offering as well as products which are marketed and sold under brands controlled by Namaste and other third-party products as specified by Namaste

VANCOUVER, British Columbia, Dec. 22, 2017 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(OTCQB:NXTTF)(FRANKFURT:M5BQ) is pleased to announce that its wholly owned subsidiary Cannmart Inc. (“Cannmart”) has signed a Fulfilment Services Agreement (the “Agreement”) with Greenlane Canada (“Greenlane”) whereby Greenlane will provide exclusive order fulfilment and warranty services for Namaste’s Canadian websites. Under the terms of the Agreement, Greenlane will fulfill orders for all products set forth in Greenlane’s product offering as well as products which are marketed and sold under brands controlled by Namaste and other third-party products as specified by Namaste. The Agreement represents a strategic decision to further align the Company with the industry’s leading business-to-business distributor, while Namaste will benefit through a significant reduction of inventory and operational expenses, bringing the company closer to profitability. Since inception, Namaste has maintained a strong working relationship with Greenlane and believes that this Agreement is accretive in nature.  In addition, it is believed this Agreement will set the framework for Namaste to collaborate with Greenlane on future opportunities in areas related to the distribution of cannabis packaging products and pre-filled cartridges for medical cannabis, to be sold in Canada through Namaste’s wholly owned subsidiary Cannmart.

Key Terms of the Agreement

  • Greenlane will provide order fulfillment for direct website and wholesale sales.
  • Greenlane will provide all services related to inventory owned and maintained by Greenlane, including pulling, packing and shipping orders.
  • Greenlane will make a one-time purchase of inventory specified by Namaste based on 360-day payment terms, to ensure adequate inventory levels.
  • Greenlane shall be responsible for warehousing of Namaste’s inventory including the costs of rent, fixtures, insurance and shrinkage.
  • Services will be rendered in a manner consistent with Greenlane’s Standard Operating Procedures (“SOP”) for its own customers as it relates to:
    • Order accuracy
    • Order processing time
    • On-time shipments
    • Packages damaged in transit
  • Greenlane will provide Namaste with access to new products added to its catalogue.
  • Greenlane will provide technical services as it relates to repairs and warranty services for Namaste’s customers.

The Agreement with Greenlane represents a key component of Namaste’s strategy moving forward, and is expected to have an immediate impact on cash-flow. The partnership further demonstrates Namaste’s commitment to focusing its resources towards the expansion of its global network, in an attempt to solidify its place in the Canadian market as the dominant player.

Additionally, Namaste remains diligent on launching medical cannabis sales in Canada, as it looks to first validate its platform and then expand into additional markets abroad. Namaste believes these combined initiatives will serve as a stepping stone in helping Namaste achieve its goal of reaching profitability, as it looks to capitalize on strategic partnerships with its peers.

Management Commentary
Aaron LoCasio, Greenlane’s CEO comments: “Sean and the Namaste team have built an exceptional company that we are proud to work alongside. This agreement further aligns our respective organizations and allows us each to focus on our core competencies. Greenlane looks forward to working with the Namaste team as we each embark on this next phase of growth.”

Sean Dollinger, President and CEO of Namaste comments: “The signing of this agreement may very well be one of the most important initiatives Namaste has implemented to date, and may be the final piece of the puzzle in helping Namaste achieve profitability. The agreement itself represent months of negotiations which has culminated with an amazing partnership with easily the most influential business-to-business distributor in the space. Our decision to partner with Greenlane was directly correlated to their amazing range of products, and proven track record in securing exclusive distribution rights for the hottest new products ahead of the competition. In addition, we believe Namaste will capture market share in the extremely exciting pre-filled hardware space by leveraging Greenlane’s exclusive access to closed system products from the leading brands. This competitive edge will be instrumental in allowing Namaste the ability to offer our customers the latest products within the Canadian market.”

About Greenlane 
Greenlane is the leading distributor of premium brands in the burgeoning head shop, smoke shop, and dispensary channels. Since 2005, Greenlane has worked diligently to build a reputation as the industry leader by meeting the needs of our customers, suppliers, and the end-users of the products we distribute. The company has achieved this by offering the most innovative products at competitive prices, providing white glove customer service, and processing orders quickly with unparalleled, highly efficient operations and logistics. During this time, Greenlane has grown to over 150 employees with operations in 7 cities across the United States and Canada, including 5 highly automated distribution centers, and continues to grow by finding ways to better serve the needs of its customers and suppliers.

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastevapes.com

Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

World Health Group: Pot’s #CBD Has Health Benefits #Marijuana $MCOA $N.ca $TBP.ca $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 4:25 PM on Tuesday, December 19th, 2017
  • Compound found in the cannabis plant is not harmful, has health benefits, and does not have abuse potential, experts at the World Health Organization say.
  • WHO’s Expert Committee on Drug Dependence focused on cannabidiol, or CBD, one of the naturally occurring cannabinoids found in cannabis plants

After reviewing evidence from animal and human studies, the committee concludes that “In humans, CBD exhibits no effects indicative of any abuse or dependence potential.”

Slideshow: Medical Marijuana

1/10

What Is Medical Marijuana?

Medical marijuana is any part of the marijuana plant that you use to treat health problems. People use it to get relief from their symptoms, not to try to get high.

Most marijuana that’s sold legally as medicine has the same ingredients as the kind that people use for pleasure. But some medical marijuana is specially grown to have less of the chemicals that cause feelings of euphoria.

The experts also say that CBD might be able to treat epilepsy (where most research has focused), although results are mixed. Other conditions it might treat are Alzheimer’s disease, Parkinson’s, anxiety, depression, and other maladies. CBD may ease inflammation, provide antioxidants, and relieve pain.

Based on its research, the committee concluded that current information does not call for scheduling of the drug. In the U.S., CBD is a Schedule 1 controlled substance. These are defined as drugs with no medical use and likely to be abused.

Twenty-nine states and Washington, D.C., have legalized the use of marijuana for recreational or medicinal purposes. Other states, including Georgia, have legalized the possession of CBD to treat specific disorders.

It remains a federal crime, however, to have or sell any form of marijuana, including CBD. Despite those federal regulations, CBD is an ingredient in popular products sold over the counter as oils, extracts, supplements, and gum to treat many ailments.

CBD usually is given as a capsule or dissolved in liquid to be taken orally, under the tongue, or as a nasal spray. CBD does not produce the high that another cannabinoid — tetrahydrocannabinol (THC) — does, experts say. In fact, CBD appears to have effects opposite of THC.

The WHO announcement drew a positive response from marijuana advocates and criticism from those who don’t want it to be legal.

The experts produced the report in November, while the WHO announced its conclusions this week. In May, the committee will study cannabis and cannabis-related substances more fully.

Other major studies have shown marijuana and its products can relieve pain, nausea related to cancer treatment, and multiple sclerosis-related muscle spasms. But using cannabis has well-known short-term and long-term health effects, such as learning and coordination problems.

Because federal law makes it a crime to have marijuana and CBD, researchers must pass strict government scrutiny just to study its usefulness.

DEA View of CBD

The conclusion of the WHO flies in the face of the view of the U.S. Drug Enforcement Administration (DEA). It says that CBD must be treated the same as THC and other cannabinoids from a cannabis plant, and it should remain a Schedule I drug.

NORML Response

Marijuana advocates applauded the WHO’s conclusion. “It was terrific to see WHO acknowledge what other scientific research has already stated,” says Justin Strekal, political director of the National Organization for the Reform of Marijuana Laws (NORML).

In an email statement, he adds: “While we are pleased to see the WHO finally acknowledge that absurdity of international restrictions, the continued domestic classification and criminalization of cannabidiol as a Schedule I controlled substance is out of step with both available science and common sense. It is yet another example of the U.S. government placing ideology over evidence when it comes to issues related to the cannabis plant.”

CALM Response

Scott Chipman, Southern California chairman of Citizens Against Legalizing Marijuana (CALM), took issue with the report.

“We need to maintain a strict scientific perspective and protocols when it comes to new drugs,” he says. “We need double-blind studies related to marijuana and all components, research on the harms versus the benefits, identification of the side effects and specific ailments identified through these studies — even for CBD,” he says.

He says some ongoing drug studies of CBD do show promise in treating seizure disorders, but he also sees potential problems with the drugs, along with concerns about contamination and other potential harms with over-the-counter products.

Source: https://www.webmd.com/a-to-z-guides/news/20171215/world-health-group-pots-cbd-has-health-benefits

INTERVIEW: Namaste $N.ca Continues Hitting Milestones Faster Than Any Other Small Cap Company We Know, WATCH NOW! $ATT.ca $ABCN.ca $ACG.ca $ACB

Posted by AGORACOM-JC at 9:57 AM on Friday, December 8th, 2017

Nlogo

We have never interviewed a client more than we’ve interviewed Namaste Technologies – and with good reason. The Company just continues to hit milestones faster than any other small cap company we know.

This can be attributed to the fact Namaste has evolved into a tech powerhouse within the medical cannabis delivery systems industry – GLOBALLY. More than just lip service, the company’s e-commerce sites are operating in 26 countries and all of them will soon be powered by Artificial Intelligence. Namaste also has 5 distribution hubs located around the world, making them the world’s largest E-Commerce B2C vaporizer company.

Does that story sound familiar? Because to us it sounds a whole lot like the beginnings of Amazon. Namaste was founded in a garage and focused on just one product. Today, it spans the globe and growing like wildfire through acquisitions, joint ventures and partnerships because EVERYONE wants to work with Namaste. Namaste is on it’s way to “Amazoning” the entire industry – and they have the Amazon blue print to follow.

The Company’s latest milestone? Surpassing $2M in monthly revenue. It’s a major one and puts Namaste into rarified air. It’s sequential 69% growth and annual 146% growth tell us the story is only getting started.

Grab a coffee, strap yourself in and watch President and CEO, Sean Dollinger, show you a glimpse into the future.